, Tracking Stock Market Picks
Enter Symbol:
Healthspring, Inc. (HS) [hlAlert]

up 38.01 %

Healthspring, Inc. (HS) rated Outperform with price target $45 by Oppenheimer

Posted on: Wednesday,  Oct 12, 2011  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Healthspring, Inc. (NYSE: HS) on 10/12/2011, when the stock price was $39.85. Since
then, Healthspring, Inc. has gained 38.02% as of 01/30/2014's recent price of $55.00.
If you would have followed this Oppenheimer's recommendation on HS, you would have gained 38.01% of your investment in 841 days.

HealthSpring is an independent Tennessee-based managed care organization. HealthSpring provides a comprehensive portfolio of healthcare benefit plans to employers in Tennessee. It is also a Medicare Advantage organization with a Medicare contract, providing plans for Medicare beneficiaries. It is dedicated to improving the health of the community and served by delivering the highest quality and greatest value in health care benefits and services. It manages both personal and company priorities.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/12/2011 8:25 AM Buy
39.85 45.00
as of 12/30/2011
1 Week down  -0.18 %
1 Month down  -0.14 %
3 Months up  36.86 %
1 YTD up  36.86 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy